Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, Ranks Fourth in 2016 Access to Medicine Index

  • The company moves up two ranks since last Index published by the Access to Medicine Foundation in 2014
  • The company has been recognized for its access-related targets that align with the United Nations Sustainable Development Goals (SDGs)
  • The company leads in capacity-building and in Intellectual Property (IP) management transparency

Protecting small children from schistosomiasis

While our well-tolerated active ingredient praziquantel can be used to treat all forms of schistosomiasis, it is not yet possible to treat children under the age of six. Within the Pediatric Praziquantel Consortium, a public-private partnership we helped co-found, we are working to alleviate this situation.

Consolidating knowledge to improve health

The WIPO Re:Search consortium catalyzes the development of new health solutions for people suffering from neglected tropical diseases, malaria and tuberculosis. As a member of this United Nations platform, we are sharing our knowledge and expertise to help improve the health of people in developing health systems.

Raising health awareness

Through the Suswastha project, we are educating rural populations in India on everyday heath issues such as coughs and diarrhea while also teaching effective prevention. Combined with free health screening and advanced training for local physicians, our efforts seek to improve the general health of people within local communities.

Reaching remote villages by boat

Only reachable by water: In the state of Madhya Pradesh, India, the River Ambulance offers primary healthcare to the people living along the remote banks of the Narmada River. We are supporting the River Ambulance, a project initiated by the NGO Narmada Samagra, and even donated a new boat at the beginning of 2016.

Dialogue – Joining forces to achieve more

It takes a team effort to build sustainable access to high-quality health solutions, which is why we engage our stakeholders at the global, national and local level. Our goal? To meet the needs of patients in underserved regions.

Access to health

Roughly 1.3 billion people currently lack access to effective and affordable healthcare. Spotlight on developing health systems: According to the World Health Organization (WHO), these countries bear 93% of the world’s disease burden, yet account for only 18% of world income and 11% of global health spending.
Industry is particularly obliged to help rectify this situation by researching, developing and refining new health solutions. But efficient health systems and distribution channels are also needed, as are affordable health products, trained medical professionals, and informed patients. 
Through programs and initiatives targeted to individual needs, we are working to help populations who lack access to diagnostics, treatment, and prevention methods. Beyond these efforts, we also foster a dialogue between various stakeholders in the health sector – only by joining forces can we overcome these challenges.


Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
Access Accelerated – joint initiative to fight non-communicable diseases